Publisher
Springer International Publishing
Reference218 articles.
1. Abu Dayyeh BK, Yang M, Fuchs BC, Karl DL, Yamada S, Shinsky JJ, O’Brien TR et al (2011) A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology 141:141–149
2. An H, Lu X, Liu D, Yarbrough WG (2011) LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild-type p53 induced phosphatase 1 (WIP1). PLoS One 6:e16427
3. Ang CS, Sun MY, Huitzil-Melendez DF, Chou JF, Capanu M, Jarnagin W, Fong Y et al (2013) c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. Anticancer Res 33:3241–3245
4. Anson M, Crain-Denoyelle AM, Baud V, Chereau F, Gougelet A, Terris B, Yamagoe S et al (2012) Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest 122:586–599
5. Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U (2014) Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma. J Pathol 233:392–401